BROOKS MABRY: Open Payments
NPI 1437769528 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,405 in 133 payments from 28 companies in 2025. Trend: 2023 $2,612 · 2024 $2,442 · 2025 $2,405
Food & beverage: $2,405
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $244 |
| Lilly USA, LLC | 16 | $218 |
| Novo Nordisk Inc | 14 | $179 |
| Otsuka America Pharmaceutical, Inc. | 12 | $179 |
| PFIZER INC. | 9 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $135 |
| GlaxoSmithKline, LLC. | 6 | $127 |
| Novartis Pharmaceuticals Corporation | 4 | $124 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $121 |
| Astellas Pharma US Inc | 4 | $119 |
Products named: MOUNJARO, REXULTI, CAPLYTA, NURTEC ODT, SHINGRIX, LEQVIO, XIFAXAN, Veozah.
Industry payments across TN — which companies pay providers there.
